Exposure of human astrocytes to leukotriene C4 promotes a CX3CL1/fractalkine-mediated transmigration of HIV-1-infected CD4+ T cells across an in vitro blood-brain barrier model

Virology

Volumn 454-455, Issue 1, 2014, Pages 128-138

  Bertin, Jonathan ^a   Jalaguier, Pascal ^a   Barat, Corinne ^a   Roy, Marc André ^a   Tremblay, Michel J ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Blood brain barrier; Central nervous system; HIV 1; Leukotrienes

Indexed keywords

CD24 ANTIGEN; FRACTALKINE; GELATINASE A; GELATINASE B; LEUKOTRIENE B4; LEUKOTRIENE C4;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CELL INVASION; CELL LINE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MACROPHAGE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; VIRUS INFECTIVITY;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; HIV-1; LEUKOTRIENES;

ASTROCYTES; BLOOD-BRAIN BARRIER; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CX3CL1; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; HIV-1; HUMANS; LEUKOTRIENE C4;

EID: 84896869470     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.02.007     Document Type: Article

References (69)

1. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
2. Adle-Biassette H., Chretien F., Wingertsmann L., Hery C., Ereau T., Scaravilli F., Tardieu M., Gray F. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 1999, 25:123-133.
3. Anthony I.C., Bell J.E. The neuropathology of HIV/AIDS. Int. Rev. Psychiatry 2008, 20:15-24.
4. Basselin M., Ramadan E., Igarashi M., Chang L., Chen M., Kraft A.D., Harry G.J., Rapoport S.I. Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats. J. Cereb. Blood Flow Metab. 2011, 31:486-493.
5. Becker Y. The spreading of HIV-1 infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes-a review, hypothesis and implications for treatment. Virus Genes 2007, 34:93-109.
6. Bertin J., Barat C., Methot S., Tremblay M.J. Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system. Retrovirology 2012, 9:4.
7. Bounou S., Leclerc J.E., Tremblay M.J. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J. Virol. 2002, 76:1004-1014.
8. Clay C.C., Rodrigues D.S., Ho Y.S., Fallert B.A., Janatpour K., Reinhart T.A., Esser U. Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J. Virol. 2007, 81:12040-12048.
9. Cotter R., Williams C., Ryan L., Erichsen D., Lopez A., Peng H., Zheng J. Fractalkine (CX3CL1) and brain inflammation: implications for HIV-1-associated dementia. J. Neurovirol. 2002, 8:585-598.
10. Crossley, K.M., Brew, B.J., 2013. Neurological complications in controlled HIV infection. Curr. Infect. Dis. Rep.
11. Cysique L.A., Brew B.J. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J. Neurovirol. 2011, 17:176-183.
12. Davis L.E., Hjelle B.L., Miller V.E., Palmer D.L., Llewellyn A.L., Merlin T.L., Young S.A., Mills R.G., Wachsman W., Wiley C.A. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992, 42:1736-1739.
13. Desmetz C., Lin Y.L., Mettling C., Portales P., Rabesandratana H., Clot J., Corbeau P. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density. Immunology 2006, 119:551-561.
14. Eugenin E.A., Clements J.E., Zink M.C., Berman J.W. Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J. Neurosci. 2011, 31:9456-9465.
15. Eugenin E.A., Osiecki K., Lopez L., Goldstein H., Calderon T.M., Berman J.W. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 2006, 26:1098-1106.
16. Feng S., Cen J., Huang Y., Shen H., Yao L., Wang Y., Chen Z. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One 2011, 6:e20599.
17. Fischer-Smith T., Croul S., Sverstiuk A.E., Capini C., L'Heureux D., Regulier E.G., Richardson M.W., Amini S., Morgello S., Khalili K., Rappaport J. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. Neurovirol. 2001, 7:528-541.
18. Fortin J.F., Cantin R., Lamontagne G., Tremblay M. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 1997, 71:3588-3596.
19. Foster A., Fitzsimmons B., Letts L.G. The synthesis of N-acetyl-leukotriene E4 and its effects on cardiovascular and respiratory function of the anesthetized pig. Prostaglandins 1986, 31:1077-1086.
20. Froldi M., Castagna A., Parma M., Piona A., Tedeschi A., Miadonna A., Lorini M., Orazio E.N., Lazzarin A. Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. J. Neuroimmunol. 1992, 38:155-161.
21. Froldi M., Parma M., Marenzi R., Piona A., Lorini M., Nobile Orazio E., Castagna A., Lazzarin A. Low levels of LTB4 in cerebrospinal fluid of AIDS patients with cryptococcal meningitis. J. Clin. Lab. Immunol. 1995, 47:41-47.
22. Gannon P., Khan M.Z., Kolson D.L. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr. Opin. Neurol. 2011, 24:275-283.
23. Genis P., Jett M., Bernton E.W., Boyle T., Gelbard H.A., Dzenko K., Keane R.W., Resnick L., Mizrachi Y., Volsky D.J., et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 1992, 176:1703-1718.
24. Gesser B., Lund M., Lohse N., Vestergaad C., Matsushima K., Sindet-Pedersen S., Jensen S.L., Thestrup-Pedersen K., Larsen C.G. IL-8 induces T cell chemotaxis, suppresses IL-4, and up-regulates IL-8 production by CD4+ T cells. J. Leukoc. Biol. 1996, 59:407-411.
25. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 1995, 38:755-762.
26. Gonzalez-Scarano F., Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 2005, 5:69-81.
27. Gramegna P., Latronico T., Brana M.T., Di Bari G., Mengoni F., Belvisi V., Mascellino M.T., Lichtner M., Vullo V., Mastroianni C.M., Liuzzi G.M. In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection. PLoS One 2011, 6:e28499.
28. Haas D.W., Clough L.A., Johnson B.W., Harris V.L., Spearman P., Wilkinson G.R., Fletcher C.V., Fiscus S., Raffanti S., Donlon R., McKinsey J., Nicotera J., Schmidt D., Shoup R.E., Kates R.E., Lloyd R.M., Larder B. Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma. AIDS Res. Hum. Retroviruses 2000, 16:1491-1502.
29. Haas D.W., Johnson B.W., Spearman P., Raffanti S., Nicotera J., Schmidt D., Hulgan T., Shepard R., Fiscus S.A. Two phases of HIV RNA decay in CSF during initial days of multidrug therapy. Neurology 2003, 61:1391-1396.
30. Haeggstrom J.Z., Funk C.D. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem. Rev. 2011, 111:5866-5898.
31. Harrington P.R., Haas D.W., Ritola K., Swanstrom R. Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells. J. Virol. 2005, 79:7959-7966.
32. Heise C.E., O,Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.S., Stocco R., Bellefeuille J.N., Abramovitz M., Cheng R., Williams D.L., Zeng Z., Liu Q., Ma L., Clements M.K., Coulombe N., Liu Y., Austin C.P., George S.R., O'Neill G.P., Metters K.M., Lynch K.R., Evans J.F. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 2000, 275:30531-30536.
33. Hu, X., Beeton, C., 2010. Detection of functional matrix metalloproteinases by zymography. J. Vis. Exp.
34. Huang X.J., Zhang W.P., Li C.T., Shi W.Z., Fang S.H., Lu Y.B., Chen Z., Wei E.Q. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation. Glia 2008, 56:27-37.
35. Husberg C., Nygard S., Finsen A.V., Damas J.K., Frigessi A., Oie E., Waehre A., Gullestad L., Aukrust P., Yndestad A., Christensen G. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J. Mol. Cell Cardiol. 2008, 45:261-269.
36. Imbeault M., Lodge R., Ouellet M., Tremblay M.J. Efficient magnetic bead-based separation of HIV-1-infected cells using an improved reporter virus system reveals that p53 up-regulation occurs exclusively in the virus-expressing cell population. Virology 2009, 393:160-167.
37. Imbeault M., Ouellet M., Tremblay M.J. Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells. Retrovirology 2009, 6:5.
38. Isozaki T., Otsuka K., Sato M., Takahashi R., Wakabayashi K., Yajima N., Miwa Y., Kasama T. Synergistic induction of CX3CL1 by interleukin-1beta and interferon-gamma in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways. Transl. Res. 2011, 157:64-70.
39. Ivey N.S., MacLean A.G., Lackner A.A. Acquired immunodeficiency syndrome and the blood-brain barrier. J. Neurovirol. 2009, 15:111-122.
40. Jones B.A., Riegsecker S., Rahman A., Beamer M., Aboualaiwi W., Khuder S.A., Ahmed S. Role of ADAM-17, p38 MAPK, cathepsins, and the proteasome pathway in the synthesis and shedding of fractalkine/CX(3) CL1 in rheumatoid arthritis. Arthritis Rheum. 2013, 65:2814-2825.
41. Josefsson L., King M.S., Makitalo B., Brannstrom J., Shao W., Maldarelli F., Kearney M.F., Hu W.S., Chen J., Gaines H., Mellors J.W., Albert J., Coffin J.M., Palmer S.E. Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc. Natl. Acad. Sci. USA 2011, 108:11199-11204.
42. Kawai T., Seki M., Hiromatsu K., Eastcott J.W., Watts G.F., Sugai M., Smith D.J., Porcelli S.A., Taubman M.A. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J. Immunol. 1999, 163:3269-3278.
43. Kolb S.A., Sporer B., Lahrtz F., Koedel U., Pfister H.W., Fontana A. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J. Neuroimmunol. 1999, 93:172-181.
44. Li Y., Kappes J.C., Conway J.A., Price R.W., Shaw G.M., Hahn B.H. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 1991, 65:3973-3985.
45. Louboutin J.P., Agrawal L., Reyes B.A., Van Bockstaele E.J., Strayer D.S. HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J. Neuropathol. Exp. Neurol. 2010, 69:801-816.
46. Louboutin J.P., Reyes B.A., Agrawal L., Van Bockstaele E.J., Strayer D.S. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy. Eur. J. Neurosci. 2011, 34:2015-2023.
47. Maccarrone M., Bari M., Corasaniti M.T., Nistico R., Bagetta G., Finazzi-Agro A. HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids. J. Neurochem. 2000, 75:196-203.
48. Matsuo M., Hamasaki Y., Fujiyama F., Miyazaki S. Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res. 1995, 685:201-204.
49. McCarthy M., Wood C., Fedoseyeva L., Whittemore S.R. Media components influence viral gene expression assays in human fetal astrocyte cultures. J. Neurovirol. 1995, 1:275-285.
50. Medina L., Perez-Ramos J., Ramirez R., Selman M., Pardo A. Leukotriene C4 upregulates collagenase expression and synthesis in human lung fibroblasts. Biochim. Biophys. Acta 1994, 1224:168-174.
51. Monteiro P., Gosselin A., Wacleche V.S., El-Far M., Said E.A., Kared H., Grandvaux N., Boulassel M.R., Routy J.P., Ancuta P. Memory CCR6+CD4+T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J. Immunol. 2011, 186:4618-4630.
52. Ohta K., Nishi H., Fukui A., Shigeishi H., Takechi M., Kamata N. CX3CL1 expression induced by Candida albicans in oral fibroblasts. FEMS Immunol. Med. Microbiol. 2010, 60:179-185.
53. Pal K., Grover P.L. A simple method for the removal of contaminating fibroblasts from cultures of rat mammary epithelial cells. Cell Biol. Int. Rep. 1983, 7:779-783.
54. Persidsky Y., Ghorpade A., Rasmussen J., Limoges J., Liu X.J., Stins M., Fiala M., Way D., Kim K.S., Witte M.H., Weinand M., Carhart L., Gendelman H.E. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 1999, 155:1599-1611.
55. Phan S.H., McGarry B.M., Loeffler K.M., Kunkel S.L. Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry 1988, 27:2846-2853.
56. Poller B., Gutmann H., Krahenbuhl S., Weksler B., Romero I., Couraud P.O., Tuffin G., Drewe J., Huwyler J. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J. Neurochem. 2008, 107:1358-1368.
57. Qi L.L., Fang S.H., Shi W.Z., Huang X.Q., Zhang X.Y., Lu Y.B., Zhang W.P., Wei E.Q. CysLT2 receptor-mediated AQP4 up-regulation is involved in ischemic-like injury through activation of ERK and p38 MAPK in rat astrocytes. Life Sci. 2011, 88:50-56.
58. Qiu L.B., Zhou Y., Wang Q., Yang L.L., Liu H.Q., Xu S.L., Qi Y.H., Ding G.R., Guo G.Z. Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats. Toxicology 2011, 285:31-38.
59. Rola-Pleszczynski M., Stankova J. Cytokine-leukotriene receptor interactions. Sci. World J. 2007, 7:1348-1358.
60. Schnell G., Joseph S., Spudich S., Price R.W., Swanstrom R. HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog. 2011, 7:e1002286.
61. Steckbeck J.D., Orlov I., Chow A., Grieser H., Miller K., Bruno J., Robinson J.E., Montelaro R.C., Cole K.S. Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains. J. Virol. 2005, 79:12311-12320.
62. Strazza M., Pirrone V., Wigdahl B., Nonnemacher M.R. Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res. 2011, 1399:96-115.
63. Vincendeau M., Kramer S., Hadian K., Rothenaigner I., Bell J., Hauck S.M., Bickel C., Nagel D., Kremmer E., Werner T., Leib-Mosch C., Brack-Werner R. Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp). AIDS 2010, 24:2433-2442.
64. Wang H., Sun J., Goldstein H. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. J. Virol. 2008, 82:7591-7600.
65. Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. Faseb J. 2005, 19:1872-1874.
66. Wherry E.J. T cell exhaustion. Nat. Immunol. 2011, 12:492-499.
67. Wu D.T., Woodman S.E., Weiss J.M., McManus C.M., D'Aversa T.G., Hesselgesser J., Major E.O., Nath A., Berman J.W. Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol. 2000, 6(Suppl. 1):S82-S85.
68. Yang Y., Estrada E.Y., Thompson J.F., Liu W., Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 2007, 27:697-709.
69. Zhao C.Z., Zhao B., Zhang X.Y., Huang X.Q., Shi W.Z., Liu H.L., Fang S.H., Lu Y.B., Zhang W.P., Tang F.D., Wei E.Q. Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats. Neuroscience 2011, 189:1-11.